These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3899472)

  • 21. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
    Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
    Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting daily maintenance dose of fluindione, an oral anticoagulant drug.
    Cazaux V; Gauthier B; Elias A; Lefebvre D; Tredez J; Nguyen F; Cambus JP; Boneu B; Boccalon H
    Thromb Haemost; 1996 May; 75(5):731-3. PubMed ID: 8725714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying an artificial neural network to warfarin maintenance dose prediction.
    Solomon I; Maharshak N; Chechik G; Leibovici L; Lubetsky A; Halkin H; Ezra D; Ash N
    Isr Med Assoc J; 2004 Dec; 6(12):732-5. PubMed ID: 15609884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study.
    Lee HL; Kan CD; Yang YJ
    Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
    Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
    Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.
    Peyvandi F; Spreafico M; Siboni SM; Moia M; Mannucci PM
    Clin Pharmacol Ther; 2004 Mar; 75(3):198-203. PubMed ID: 15001971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
    Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
    Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
    J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
    Warrington SJ; Johnston A; Lewis Y; Murphy M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
    Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
    Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
    Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
    Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.